May 2018 Briefing - Ophthalmology

This article originally appeared here.
Share this content:

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

FDA Approves First Artificial Iris

THURSDAY, May 31, 2018 (HealthDay News) -- The first artificial iris has been approved by the U.S. Food and Drug Administration for patients with aniridia.

More Information

ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care

THURSDAY, May 31, 2018 (HealthDay News) -- The widespread shortages of injectable opioids and small-volume parenteral (SVP) solutions are jeopardizing patient care and placing a strain on hospital operations, according to a report published by the American Society of Health-System Pharmacists (ASHP).

More Information

Congress Approves Bill Expanding Private Care for VA Patients

THURSDAY, May 24, 2018 (HealthDay News) -- Patients served by the beleaguered Veterans Affairs health system may have wider access to private care, thanks to a bill approved Wednesday by the Senate. President Donald Trump is known to support the bill, which now awaits his signature.

AMA Statement
More Information

Global Variation in Personal Health Care Access and Quality

THURSDAY, May 24, 2018 (HealthDay News) -- There is considerable global variation in personal health care access and quality, according to a study published online May 23 in The Lancet.

Abstract
Full Text
Editorial

CDC: No Change in Level of Uninsured in U.S. in 2017

TUESDAY, May 22, 2018 (HealthDay News) -- Overall, 9.1 percent of individuals in the United States were uninsured in 2017, which was not significantly different from the level in 2016, according to a report published online May 22 by the U.S. Centers for Disease Control and Prevention's National Centers for Health Statistics.

Abstract/Full Text

Semaglutide Found to Be Effective Against Type 2 Diabetes

MONDAY, May 21, 2018 (HealthDay News) -- Semaglutide is safe and effective for the treatment of type 2 diabetes, according to a review published online May 13 in Diabetes, Obesity and Metabolism.

Abstract/Full Text (subscription or payment may be required)

Language Used in Medical Record Can Affect Patient Care

FRIDAY, May 18, 2018 (HealthDay News) -- Stigmatizing language used in medical records to describe patients can influence medical students and residents in terms of their attitudes towards the patient and their clinical decision-making, according to a study published in the May issue of the Journal of General Internal Medicine.

Abstract/Full Text

Nonprofit Manufacturer Could Keep Generic Drug Costs Down

WEDNESDAY, May 16, 2018 (HealthDay News) -- A nonprofit manufacturer could help keep generic drug prices down and maintain their supply, according to a perspective piece published in the May 17 issue of the New England Journal of Medicine.

Abstract/Full Text

Best Practices Developed for Use of EHR to Enhance Patient Care

WEDNESDAY, May 16, 2018 (HealthDay News) -- Best practices have been developed for using electronic health records (EHRs) to enhance patient-centered care, according to an article published online in Medical Economics.

Abstract/Full Text

Uveal Effusion Reported After Initiation of Anti-PD-1, -PD-L1

THURSDAY, May 10, 2018 (HealthDay News) -- Patients receiving immunotherapy with antiprogrammed cell death protein-1 (anti-PD-1) and antiprogrammed cell death ligand-1 (anti-PD-L1) monoclonal antibodies may develop uveal effusion, according to a report published online April 12 in JAMA Ophthalmology.

Abstract/Full Text (subscription or payment may be required)

FDA Targets Clinics Offering Unapproved Stem Cell Therapies

THURSDAY, May 10, 2018 (HealthDay News) -- The U.S. Food and Drug Administration has launched legal action to stop two stem cell clinics from providing unapproved treatments that have caused serious, long-term harm to some patients.

More Information

Extended Range of Vision Lens Found Superior to Monofocal

THURSDAY, May 10, 2018 (HealthDay News) -- Extended range of vision (ERV) intraocular lens (IOL) targeted to achieve micro-monovision shows superior range of visual acuity and independence from glasses compared to the monofocal IOL targeted to achieve emmetropia, according to a study published online May 3 in Clinical & Experimental Ophthalmology.

Abstract/Full Text (subscription or payment may be required)

Regulatory Requirements Drive Dissatisfaction With EHRs

TUESDAY, May 8, 2018 (HealthDay News) -- Regulatory requirements are likely to be an important aspect of physician dissatisfaction with electronic health records (EHRs) that is driving burnout, according to an Ideas and Opinions piece published online May 8 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

Automated Algorithm Accurately IDs Plus Disease in ROP

TUESDAY, May 8, 2018 (HealthDay News) -- A fully automated algorithm can accurately diagnose plus disease in retinopathy of prematurity (ROP), according to a study published online May 2 in JAMA Ophthalmology.

Abstract/Full Text

Eyes of Ebola Survivors Show Localized Pathological Changes

MONDAY, May 7, 2018 (HealthDay News) -- Survivors of Ebola virus disease (EVD) have localized pathological changes in photoreceptors, according to a study published online May 3 in JAMA Ophthalmology.

Abstract/Full Text
Editorial (subscription or payment may be required)

Many Organizations Not Meeting Trial Reporting Requirements

FRIDAY, May 4, 2018 (HealthDay News) -- Many organizations are not meeting the trial registration and results reporting requirements clarified by "The Final Rule," which had a compliance date of April 18, 2017, according to a study published online May 1 in BMC Medicine.

Abstract/Full Text

Punctal Plug Deemed Beneficial in Ocular Surface Disease

FRIDAY, May 4, 2018 (HealthDay News) -- For patients with ocular surface disease (OSD) using prostaglandin analogue monotherapy, a punctal plug improves OSD and reduces intraocular pressure (IOP), according to a study published online April 26 in Clinical & Experimental Ophthalmology.

Abstract/Full Text (subscription or payment may be required)

In Retinoblastoma Survivors, Oculo-Visual Issues Tied to QoL

WEDNESDAY, May 2, 2018 (HealthDay News) -- Oculo-visual problems among adult retinoblastoma survivors are associated with patient-reported vision-targeted health-related quality of life (HRQoL), according to a study published online April 26 in JAMA Ophthalmology.

Abstract/Full Text (subscription or payment may be required)

Practices Should Be Aware of Correct Way to Fire Employees

TUESDAY, May 1, 2018 (HealthDay News) -- Physicians should be aware of the correct protocol for, as well as the laws involved in, firing employees, according to a report published in Medical Economics.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Florida Teen First Human Case of Another Mosquito-Borne Virus

Florida Teen First Human Case of Another Mosquito-Borne ...

First documented case of Keystone infection in a human

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

Illnesses reported in Illinois, Indiana, Kentucky, Michigan, Missouri, Ohio, and Tennessee

AAFP Still Recommends CRC Screening From Age 50 to 75

AAFP Still Recommends CRC Screening From Age 50 ...

Despite ACS change to start screening from age 45 years, AAFP agrees with USPSTF recommendation

is free, fast, and customized just for you!




Already a member?

Sign In Now »